	Latent density discrepancies in commercial lung-equivalent inserts and their clinical dosimetric impact. J Appl Clin Med Phys Nakao M, Ozawa S, Miura H, Hayata M, Habara K, Kenjo M. PMID: 42348060 [PubMed - indexed for MEDLINE]
	Multi-Task and Federated Learning for Breast and Lung Cancer Screening and Diagnosis: A Survey and Future Research Directions. J Imaging Ciobotaru A, Corches C, Gota D, Miclea L. PMID: 42346921 [PubMed]
	Comparative Prognostic Performance of CARWL and Naples Prognostic Score in Stage IIIC Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Med Sci (Basel) Topkan E, Ozturk D, Selek U. PMID: 42346849 [PubMed - indexed for MEDLINE]
	Image-Guided Thermal Ablation of Stage 1 Single and Multiple Primary Lung Carcinoma: Five-Year Outcomes. Med Sci (Basel) Clarke JE, Jahanshahi N, Villegas B, Kim GHJ, Kooraki S, Quirk M, Genshaft S, Suh RD, Abtin F. PMID: 42346811 [PubMed - indexed for MEDLINE]
	Pituitary Metastasis in Lung Cancer Patients: Case Series and Review of the Literature. Curr Oncol Ntouraki S, Roumpou A, Asimakopoulou A, Gkiozos I, Sarropoulou F, Mani M, Marioli A, Bouklas D, Syrigos K, Peppa M. PMID: 42346262 [PubMed - indexed for MEDLINE]
	Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC. Curr Oncol Selke J, Dzierma Y, Manda K, Hildebrandt G, Frerker B, Kalata P, Ackermann C, Bock F. PMID: 42346251 [PubMed - indexed for MEDLINE]
	Predicting Postoperative Complications in Lung Cancer Spinal Metastases: A Nomogram Based on Nutritional, Low Psoas Muscle Index, and Functional Status. Curr Oncol Lv X, Zhao R, Fan Y, Wang Z, Fang X, Qiao J. PMID: 42346236 [PubMed - indexed for MEDLINE]
	Prognostic Factors and Survival in Surgically Treated Stage III Non-Small Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort Study. Curr Oncol Elma B, Kumbasar HZ, Dogan I, Ulusan A, Sanli M, Isik AF. PMID: 42346216 [PubMed - indexed for MEDLINE]
	Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review. Curr Oncol Portu M, Sanz-Beltran J, Duarte Borges MA, Navarro J, Arias A, Alvarez P, Fernández-Rebollo A, Reyes C, Flores J, Anguera G, Maroto P. PMID: 42346214 [PubMed - indexed for MEDLINE]
	Integrating Exercise and Education into Lung Cancer Care: Results from the OVER-CRF Pilot Study on Cancer-Related Fatigue and Quality of Life. Curr Oncol Galavotti MB, Pecorari A, Mainini C, Denti M, Messori M, Costi S, Bressi B, Pellegrini M, Ciammella P, Falco F, Zanelli F, Braglia L, Fugazzaro S. PMID: 42346213 [PubMed - indexed for MEDLINE]
	Transition from Parenteral to Subcutaneous Application of Systemic Oncological Therapy for Treating Non-Small-Cell Lung Cancer. Curr Oncol Muratovic A, Janzic U. PMID: 42346207 [PubMed - indexed for MEDLINE]
	Impact of primary tumor SUVmax on PET accuracy in mediastinal lymph node staging of non-small cell lung cancer (NSCLC). Adv Clin Exp Med Ku, Gambu, Moszczy, Popovchenko S, Bryndza M, Rudnicka L, Warmus J, Hauer J, , Trybalski , Koco. PMID: 42345501 [PubMed - as supplied by publisher]
	Synergistic Deep Learning Fusion for Precision Lung Cancer Staging. Asian Pac J Cancer Prev P S, Albert AJ, M M, G G, S R. PMID: 42345183 [PubMed - indexed for MEDLINE]
	Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer. Future Oncol Tsvetkova O, Gil TE, Kassir G, Castanon S, Kollapaneni SS, Han A, Park SJ, Li R, Velez MA, Lisberg AE. PMID: 42345080 [PubMed - as supplied by publisher]
	Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs. Front Immunol Mao W, Tang Z, Chen Y, Chen Y, Zhang S, Feng X, Zhang S. PMID: 42344916 [PubMed - indexed for MEDLINE]
	Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and meta-analysis. Front Immunol Wang Y, Wu S, Wei Y, Fan S, Xu Z, Li D, Teng Z, Wang J. PMID: 42344896 [PubMed - indexed for MEDLINE]
	Spatiotemporal heterogeneity in non-small cell lung cancer: A paradigm shift from characterization to dynamic management (Review). Oncol Lett Cao L, Zhang W. PMID: 42344719 [PubMed]
	Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer. Acta Neuropathol Commun Guan X, Li Y, Shi Z, An J, Hua Y, Ding X, Zheng X, Xu W, Zhang D, Xue Z, Kang P, Cao D, Li X, Jia W. PMID: 42343476 [PubMed - as supplied by publisher]
	Therapeutic outcomes of PD-1 blockade-related regimens versus docetaxel in previously immunotherapy-treated advanced non-small cell lung cancer: a retrospective, exploratory study. BMC Cancer Huang TT, Wang XY, Li Q, Song PF. PMID: 42343297 [PubMed - as supplied by publisher]
	Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial. Nat Med Huang Z, Zeng L, Ruan Z, Zeng Q, Yan H, Jiang W, Xiong Y, Zhou C, Yang H, Liu L, Dai J, Zou N, Xu S, Wang Y, Wang Z, Deng J, Chen X, Wang J, Xiang H, Li X, Duchemann B, Chen G, Xia Y, Mok T, Scheiermann C, Lévi F, Yang N, Zhang Y. PMID: 42343117 [PubMed - as supplied by publisher]

Articles 1 - 20 / 159761

Page 1 of 7989



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy